CBD Stocks: Who Should You Watch in 2019? CARA, ISOL, and TGIF

CBD stocks

Investing in CBD stocks is growing in popularity, and it's no surprise as to why. Canada has legalized cannabis entirely, and the US has recently passed its updated Farm Bill legalizing hemp farming. Now, the CBD industry is able to finally take flight.

With that in mind, we're checking out some of the hottest CBD stocks on the radar for 2019.

CBD Stocks: What is CBD?

CBD (cannabidiol) is a component found within the cannabis plant. Utilized for its health benefits, it can be extracted from both hemp and marijuana flower. As CBD is now legally industrialized, the list of CBD-focused companies looking to be a part of an expected $3 billion USD industry by 2020 is growing. 

CBD Stocks to Watch

As a potential investor of CBD stocks, you will be entering into one of the hottest new industries at a vital time. Finding the best CBD stocks now might pay off dividends in the future, so here are three companies where CBD itself is incremental to their business.

Cara Therapeutics (NASDAQ:CARA)

One of the most promising CBD stocks to watch in 2019 is Cara Therapeutics. The Connecticut-based company uses extracts from the cannabis plant as its primary ingredient in its pain alleviation and itch treatments.

The company is taking the focus away from highly-addictive opioids, which currently comprise most pain-relief medicines. Instead, it is developing pain management products from marijuana properties.

The Cara Therapeutics CBD stock is selling for $15.34 USD at the time of writing. 

>> OrganiGram Up Nearly 5% Despite Class-Action Lawsuit

Isodiol International Inc. (CSE:ISOL) (OTCQB:ISOLF)

On the other end of the price scale, selling for only $1.83 CAD at the time of writing, is one of the top providers of hemp-derived CBD products, Isodiol International. This CBD stock could be a good option for investors who want to opt for a company with a proven track record but want to buy in at a reasonable price.

Isodiol International focuses on the medical benefits of CBD-based products and places a strong emphasis on education surrounding CBD and medical marijuana.

1933 Industries Inc (CSE:TGIF) (OTCQX:TGIFF)

1933 Industries was pulling in strong revenue before Canada and the US both changed their laws. With sales of $5.4 million as of April 2018, it makes sense that the company now expects an even bigger demand for its CBD-infused wellness products in 2019.

1933 Industries comes with a good reputation and loyal consumer-base who use its products primarily for medical reasons. At the time of writing, the TGIF CBD stock is selling for $0.42 CAD.

 

Featured Image: Depositphotos © Omstudio

If You Liked This Article Click To Share